Originator Organization Oncocross Co., Ltd.Startup |
Active Organization Oncocross Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | Oncocross Co., Ltd.Startup | 30 Nov 2022 |